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• Intrathecal  injection  of  the gene-cell  constraction  was  used  for  the  ﬁrst  time  for  SCI treatment  in large  animal  mini-pig  SCI  model.
• Results  provide  evidence  of  feasibility  and  potential  efﬁcacy  of  proposed  UCBC-based  delivery  of  three  therapeutic  genes  therapy.
• Observed  recovery  in  treated  animals  support  the  positive  effect  of the  gene-cell  constriction  after  SCI.
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Currently,  in clinical  practice  there  is no  efﬁcient  way  to overcome  the sequences  of  neurodegeneration
after  spinal  cord  traumatic  injury.  Using  a new  experimental  model  of  spinal  cord  contusion  injury  on
miniature  pigs,  we proposed  to deliver  therapeutic  genes  encoding  vascular  endothelial  growth  factor
(VEGF),  glial cell  line-derived  neurotrophic  factor  (GDNF)  and  neural  cell  adhesion  molecule  (NCAM)  to
the damaged  area,  using  umbilical  cord  blood  mononuclear  cells  (UCBC).  In this  study,  genetically  engi-
neered  UCBC  (2 ×  106 cells  in  200  ml  of saline)  were  injected  intrathecally  to mini-pigs  10  days  after  SCI.
Control  and  experimental  mini  pigs  were  observed  for  60 days  after  surgery.  Histological,  electrophysio-
logical,  and  clinical  evaluation  demonstrated  signiﬁcant  improvement  in  animal  treated  with  genetically
engineered  UCBCs.  Difference  in  recovery  of  the  somatosensory  evoked  potentials  and  in histological  ﬁnd-
ings in control  and  treated  animals  support  the  positive  effect  of  the  gene-cell  constriction  for  recovery
after  spinal  cord  injury.  Results  of this  study  suggest  that  transplantation  of UCBCs  simultaneously  trans-
duced  with  three  recombinant  adenoviruses  Ad5-VEGF,  Ad5-GDNF  and  Ad5-NCAM  represent  a novel
potentially  successful  approach  for treatment  of  spinal  cord  injury.
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1. Introduction
Spinal cord injury (SCI) is classiﬁed as a neurotrauma, although it
is followed by disturbance in blood supply, neurodegenerative and
other pathological consequences [1]. Regardless numerous animal
studies and clinical trials, to this time there is no successful clinical
protocol for SCI treatment. To enhance the efﬁcacy of SCI therapy
along with experiments on rodents and clinical trials, experiments
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